GLP-1 Drug Market – Oral Therapies Expand Access Beyond Injectable Care
Oral GLP-1 therapies are emerging as an important opportunity in the GLP-1 drug market. While subcutaneous injections currently dominate with approximately 64% market share, oral formulations are expected to grow quickly as patients seek less invasive and more convenient treatment options.marketresearchfuture Injectable GLP-1 therapies remain central to the market because they have established...
0 Comments 0 Shares 119 Views 0 Reviews